Fig. 1From: Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance statusA comparison of survival curves between chemotherapy and BSC groups. A comparison of survival curves is shown. The overall survival (OS) was better in the chemotherapy group than in the BSC groupBack to article page